Charles River Laboratories International, Inc. News Headlines

CRL 
$68.79
*  
0.43
0.63%
Get CRL Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading CRL now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Charles River Beats on Q2 Earnings & Revenues, Outlook Upped - Analyst Blog
8/7/2014 1:10:00 PM - Zacks.com


Acorda Beats on Q2 Earnings & Revenues, Maintains View - Analyst Blog
8/4/2014 8:20:00 AM - Zacks.com


MedAssets to Help Centegra Health System Build ACO Model - Analyst Blog
7/15/2014 5:13:00 PM - Zacks.com


Progenics-Salix Up on Encouraging Relistor News - Analyst Blog
7/15/2014 3:45:00 PM - Zacks.com


Cramer's Mad Money - Piggyback On Peltz (7/14/14)
7/15/2014 6:00:00 AM - Seeking Alpha


Allergan Slides as Migraine Drug Fails to Win Approval - Analyst Blog
7/1/2014 3:30:00 PM - Zacks.com


Charles River Laboratories International Breaks Above 200-Day Moving Average - Bullish for CRL
7/1/2014 10:41:26 AM - BNK Invest


Valeant's Jublia Approved in the U.S. - Analyst Blog
6/10/2014 4:50:00 PM - Zacks.com


Sanofi's Lemtrada Accepted for FDA Review - Analyst Blog
6/2/2014 6:14:00 PM - Zacks.com


InterMune Resubmits Esbriet NDA - Analyst Blog
5/28/2014 5:18:00 PM - Zacks.com


EU Nod for Eli Lilly/Boehringer's Jardiance (revised) - Analyst Blog
5/28/2014 1:26:32 PM - Zacks.com


CHMP Negative on Novartis' RLX030 - Analyst Blog
5/27/2014 5:15:00 PM - Zacks.com


EU Nod for Eli Lilly/Boehringer's Jardiance - Analyst Blog
5/27/2014 10:50:00 AM - Zacks.com


Charles River Laboratories International (CRL) Shares Cross Below 200 DMA
5/22/2014 3:19:24 PM - BNK Invest


Setback for Novartis' RLX030 - Analyst Blog
5/16/2014 4:10:00 PM - Zacks.com


Salix Q1 Earnings Boosted by Santarus Acquisition - Analyst Blog
5/9/2014 12:41:00 PM - Zacks.com


Acorda Misses on Earnings, Beats Revs - Analyst Blog
5/7/2014 12:43:01 PM - Zacks.com


Biotech Stock Roundup: Endocyte Tumbles & Merrimack Soars on Pipeline News - Analyst Blog
5/7/2014 8:34:01 AM - Zacks.com


Dynavax Reports In Line Q1 Results - Analyst Blog
5/6/2014 10:50:01 AM - Zacks.com


Acorda Down on Plumiaz CRL - Analyst Blog
5/5/2014 2:12:01 PM - Zacks.com


Charles River Laboratories (CRL) is now in Oversold Territory - Tale of the Tape
5/2/2014 8:50:01 AM - Zacks.com


CRL for The Medicines Co.'s Cangrelor - Analyst Blog
5/1/2014 3:05:01 PM - Zacks.com


Charles River Beats on Earnings, Guidance Upped - Analyst Blog
5/1/2014 2:34:01 PM - Zacks.com


Charles River Laboratories International Breaks Below 200-Day Moving Average - Notable for CRL
5/1/2014 10:27:34 AM - BNK Invest


Express Scripts Misses Earnings, Guides Low - Analyst Blog
4/30/2014 10:50:01 AM - Zacks.com